Livi Post-Sex Vaginal Device: Hmmmm

Summary

---

Episode Overview

Podcast: Dr. Chapa’s OBGYN Clinical Pearls
Episode: Livi Post-Sex Vaginal Device: Hmmmm
Date: April 9, 2026
Host: Dr. Chapa

In this quick-hit episode, Dr. Chapa reviews and critiques the new FDA-cleared Livy post-intercourse vaginal absorption device. Meant to absorb residual semen after vaginal intercourse, Livy is being marketed as a way to restore vaginal pH, manage post-coital "drip," and—by implication—possibly help with recurrent bacterial vaginosis (BV). Dr. Chapa provides evidence-based context, points out the limitations of current knowledge, and offers practical guidance for clinicians who may field questions about the product from patients or social media.

---

Key Discussion Points & Insights

1. What is the Livy Device?

• Description: Livy is described as "the first FDA cleared post-intercourse vaginal absorption device"—essentially a polyurethane, tampon-like single-use product to absorb semen after sex.
• Intended Use: Inserted after vaginal sex, left in for 60 seconds to 15 minutes, then removed and discarded.
• Target Audience: Those annoyed by post-coital "drip" and especially patients dealing with recurrent BV (bacterial vaginosis).

---

2. Is the Concept Evidence-Based?

• Known Data: There’s strong evidence that semen exposure in the vagina alters the vaginal microbiome, increasing the risk for both new and recurrent BV.
  • “There is absolute data that nobody argues with that semen exposure into the vagina alters the vagina microbiome and increases the risk of both occurrence and recurrence of BV. That's a no brainer.” (Dr. Chapa, 02:28)
• What’s Unknown: There is NO data showing that the duration of semen residence in the vagina—i.e., how quickly it's removed—affects BV risk.
  • “What is unknown... is when you... say that residence time in the vagina is an adverse risk factor. We really don't know that. That's an extrapolation.” (Dr. Chapa, 03:03)
• Extrapolation Problem: The foundation is sound (semen = BV risk), but it’s a leap to say removing semen faster helps prevent BV.
  • “As of right now, the data is kind of binary for semen exposure into the vagina. It's either yes or no...” (Dr. Chapa, 03:19)

---

3. Published Data & Feasibility Study

• Feasibility Study: Only data is a small abstract (n = 184) published in 2025. It looked at whether users felt reduced "drip" and discomfort—not BV recurrence.
  • “Did it do what it said it was going to do? Did you feel less drip, did you feel less uncomfortable after sex... They’re like, ‘yeah, it did what it’s supposed to do.’ But that’s hardly a win for BV recurrence prevention.” (Dr. Chapa, 07:13)
• Marketing vs. Claims: The press release language is cautious: it says Livy “restores natural pH, helping to manage odor, dripping, and discomfort” rather than stating it can prevent BV. (07:03)

---

4. Historical Context: Douching

• Failed Interventions: Douching after sex — once considered protective — actually increases BV risk and other infections by disrupting the protective vaginal flora.
  • “Douching was, like, supposed to help prevent BV. It did the exact opposite. It increased BV, mainly because you washed out all the protective lactobacilli.” (Dr. Chapa, 08:24)

---

5. Other Evidence-Based BV Prevention Strategies

• Partner Treatment: Recent ACOG endorsement of treating male partners for recurrent BV prevention.
  • “Remember that ACOG has endorsed partner treatment or treatment of the male partner for recurrent BV prevention.” (Dr. Chapa, 10:33)
• Vaginal Acidification: Modest, moderate evidence for benefit.
• Vaginal Probiotics: Conflicting but possibly beneficial as adjuvant or standalone.

---

6. Safety & Cautions with Livy

• Device Use:
  • Do not leave Livy inserted for more than 15 minutes—could absorb beneficial fluids.
  • Do not forget to remove it (risk paralleling forgotten tampons and possible complications).
  • “Number one, don’t leave that in for longer than 15 minutes... Number two, don’t forget it in there, because I could just see... like the forgotten tampon.” (Dr. Chapa, 12:11)
• Unknown Long-Term Impact: Possible unintended consequences, such as removing protective secretions.

---

7. Practical Takeaways & Clinician Guidance

• Be Ready for Patient Questions: Social media buzz means patients may ask.
• Current Stance: If a patient wants to try it for comfort, fine—but there is no evidence to support claims for BV recurrence prevention. Be honest about the limitations.
  • “My answer is going to be, we just don't know. If it makes you feel better after sex and you want to spend whatever it costs to go get this, fine.” (Dr. Chapa, 11:38)

---

Notable Quotes & Memorable Moments

• On the evidence gap:
  “Is this legit? So we're doing this in a very quick fashion... because, yeah, it's kind of out there.” (Dr. Chapa, 01:54)

• On douching and lessons learned:
  “So douching is terrible. That's a no, no. We know not to do that.” (Dr. Chapa, 09:05)

• On the market future:
  “I don't know if this is going to last on the market, if it's going to be like a multi billion dollar—like a douching company is multi million dollar. We don't know.” (Dr. Chapa, 09:38)

• Final advice:
  “If it makes you feel better after sex and you want to spend whatever it costs to go get this, fine... I wanted to let you know what’s coming out very quickly on the market.” (Dr. Chapa, 11:44)

---

Timestamps for Important Segments

| Timestamp | Segment Description | |-----------|--------------------------------------------------------------| | 01:31 | Dr. Chapa introduces the episode and Livy device | | 02:28 | Evidence of semen exposure and BV risk | | 03:03 | Limits of current scientific knowledge on residence time | | 07:03 | Review of existing Livy study/press release | | 08:24 | Historical look at douching and BV | | 10:33 | Evidence-based approaches to BV prevention | | 12:11 | Safety cautions for Livy use | | 13:00 | Practical clinician advice and summary |

---

Episode Summary

Dr. Chapa offers a nuanced, evidence-focused look at the soon-to-launch Livy vaginal device, clarifying that while the theoretical link between semen exposure and BV recurrence is sound, there is no current evidence that removing semen faster alters that risk. The only data on Livy is on subjective comfort, not clinical endpoints. Douching is a well-documented error of the past, and enthusiasm for Livy should be tempered by history and science. Until more is known, clinicians should be ready to give patients balanced, data-driven advice: use Livy for comfort if desired, but do not expect it to prevent BV.

Transcript

[Narrator]

No one goes to Hank's for spreadsheets. They go for a darn good pizza. Lately, though, the shop's been quiet. So Hank decides to bring back the $1 slice. He asks copilot in Microsoft Excel to look at his sales and costs and help him see if he can afford it. Copilot shows Hank where the money's going and which little extras make the dollar slice work. Now Hanks has a line out the door. Hank makes the pizza. Copilot handles the spreadsheets. Learn [e-mail] work we gather here tonight

[Dr. Chapa]

to bring women back to their rightful place.

[Hulu Advertiser]

The Testaments, a new Hulu original series from the executive producers of the Handmaid's Tale.

[Nordstrom Rack Advertiser]

It's easier to accept a story than believe that the people around you are monsters.

[Hulu Advertiser]

The battle isn't over.

[Nordstrom Rack Advertiser]

There comes a time when you have

[Dr. Chapa]

to take action, when you have to

[Nordstrom Rack Advertiser]

choose your own destiny.

[Pharmaceutical Advertiser]

Never quite hesitating.

[Hulu Advertiser]

Watch the new Hulu original series, the Testaments, streaming on Hulu and Hulu on Disney plus for bundle subscribers. Terms apply.

[Livy Device Advertiser]

Ladies annoyed by that pesky post intercourse vaginal semen drip? Of course, who wouldn't be? Well, now there is Livy. The first FDA cleared post intercourse vaginal absorption device. That's right. It's Livy to the rescue. Is this evidence based, Dr. Chapa? Tell us more.

[Dr. Chapa]

All right, so I have to tell you, I'm innocent in that intro. Innocent. Michael, our producer said, hey, I'm going to get someone to do the intro read for the Livy script and it's going to be like one of those infomercials. I said, man, you know, you do you a little over the top, Michael. A little over the top.

[Livy Device Advertiser]

Ladies annoyed by that pesky post intercourse vaginal semen drip.

[Dr. Chapa]

Oh, my goodness. Oh, my goodness. Let's just stop there. So, yeah, so I posted this on our Instagram and I got various messages saying, hey, could you do a little episode on this? Even though you gave some information on the real, could you just give us more info and data on this? Is this legit? So we're doing this in a very quick fashion as a quickie episode because, yeah, it's kind of out there. There is now the first FDA cleared, not approved, cleared post intercourse vaginal absorption device. It's actually not a device at all. It's kind of like a little tampon that's polyurethane that is meant to absorb leftover seminal semen secretions after doing the horizontal mambo. Now here's the catch. This isn't just about that annoying post intercourse drip. It's actually aimed or will be aimed towards the BV recurrence crowd. All right, recurrence. BV is an issue. It sucks, we get it. But that's why now there's the potential for partner therapy that's now ACOG endorsed. We've covered that on this show. The question though is, is this idea of removing seminal fluid quickly from the vagina, is that legit? Is that evidence based on. So this is where it gets a little hairy, a little tricky because you can start with sound concept and theory. And this is based on sound concept and theory. There is absolute data that nobody argues with that semen exposure into the vagina alters the vagina microbiome and increases the risk of both occurrence and recurrence of bv. That's a no brainer. What is unknown, however, is when you start from that and leap forward into a pool of the unknown and say it must also imply that residence time in the vagina is an adverse risk factor. In other words, increases the risk of bv. We really don't know that. That's an extrapolation. So once again, as of right now, the data is kind of binary for semen exposure into the vagina. It's either yes or no. And if it is yes, the vagina has exposure to semen that is an independent risk factor for BV occurren and recurrence. What we don't know is does it matter how long it sits in the vagina? Is that also a factor? Nobody's actually looked at that. All right. And actually, actually there has been one behavioral lifestyle intervention that's been proposed to remove semen seminal fluid from the vagina after sex. That actually did not work at all. Actually, it was much worse. And I'll talk about that after the intro. Anyway, I think I've set it up enough. This is the episode on the new FDA cleared post intercourse vaginal absorption device Livy, that's supposed to be marketed out to the mass population in May of 2026. Guys, that's just next month. So I think I've set it up enough. We'll be right back.

[Livy Device Advertiser]

So good, so good, so good.

[Nordstrom Rack Advertiser]

New markdowns, up to 70% off are at Nordstrom Rack stores now. And that means so many new reasons to rack.

[Livy Device Advertiser]

Cause I always find something amaz.

[Dr. Chapa]

Just so many good brands because there's always something new.

[Nordstrom Rack Advertiser]

Join the NordicLub to unlock exclusive discounts. Shop new arrivals first and more. Plus buy online and pick up at your favorite rack store for free. Great brands, great prices. That's why you Rack Eczema is unpredictable, but you can flare less with ebglis, a once monthly treatment for moderate to severe eczema after an initial four month or longer dosing phase. About four in ten people taking ebglis achieved itch relief and clear or almost clear skin at 16 weeks, and most of those people maintain skin that's still more clear at one year with monthly dosing.

[Pharmaceutical Advertiser]

HempGlass Lebricizumab LBKZ, a 250mg injection, is a prescription medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds or 40 kilograms with moderate to severe eczema, also called atopic dermatitis that is not well controlled with prescription therapies used on the skin or topicals or who cannot use topical therapies. Ebglis can be used with or without topical corticosteroids. Don't use if you're allergic to ebglis. Allergic reactions can occur that can be severe. Eye problems can occur. Tell your doctor if you have new or worsening eye problems. You should not receive a live vaccine when treated with Epglis. Before starting Epglis, tell your doctor if you have a parasitic infection.

[Nordstrom Rack Advertiser]

Ask your doctor about Eglis and Visit or call 1-800-LILYRX or 1-800-545-5979.

[Dr. Chapa]

Podcast Family welcome to another quickie episode of the Clinical Pearls no Spin podcast. All right, Podcast family, we're doing this as a quickie episode. It's going to be very fast because there's not a lot of product data here. So we just want to remind ourselves of what seems to work and what doesn't for BV recurrence. First of all, Livy, not a sponsor, is being made by Livy. Well and yes, this has set as a target date for release at the end of May of 2026. This is a little specified modified tampon like device that goes into the vagina after penile vaginal sex and the idea is to absorb semen from the vaginal milieu and it can be left in place for 60 seconds although it can stay in in the vagina for about 15 minutes. Then you got to take it out. It is single use, don't be gross and then you throw it away. Does this work? And this is meant to try to quote that I'm reading directly from the press release quote to restore natural ph, helping to manage odor dripping and discomfort, end quote. So you see, so they're, they're very cautious here because they can't make the claim that it reduces bv. Can't do that because I don't have the data. But you notice how they get around that quote, restoring the natural ph, end quote. Well, we really don't have that data. We do have a small abstract that was published on this, basically like a feasibility study with an N of 184 patients that was published in 2025. And I posted that on our Instagram page. But it was basically, did it do what it said it was going to do? Did you feel less drip, did you feel less uncomfortable after sex in terms of moisture and maybe some secretions? And they're like, yeah, I mean, it did what it's supposed to do. But that's hardly a win for BV recurrence prevention. Okay, now as I mentioned in the intro, there is absolutely data that exposure of semen to the vagina changes the environment of the vagina and leads to bv, both as the new occurrence and obviously as a recurrence. And the thought is that semen not only does that on a chemical basis by changing the ph, because, you know, it's more alkaline, of course, of the vagina is acidic, but also as a microbial basis because semen carries with it, of course, bacteria from the penis and just the active penetration by itself introduces penile bacteria into the vagina. So it's very complicated here. Okay? But yes, there's absolute data that semen exposure into the vagina leads to bv. And there's actually looked at this even in an indirect way, days later. So patients were said, you know, recruited, hey, if you have sex coming in, we'll swab you a couple of days later and they'll look for PSA prostate specific antigen. And for sure, I mean, without a doubt, those who tested positive for PSA had a higher risk of getting bv. I mean, so there is something to that. So that's true. What is unclear if it's true or not is does it matter how long it stays in the vagina? We don't know that right now. It seems to be binary. Semen exposure leads to increased risk of bv. Yes. No, semen exposure reduces the risk of bv. Yes, that's binary, one or the other. There is no data, at least no hard data right now, that it is significantly increased in terms of the risk of BV if the semen stays in the vagina for longer periods of time. We don't know that historically, like we're talking 70s and 80s, douching was, like, supposed to help prevent BV. So there was a concept that if you douched after penile vaginal sex, it would reduce BV occurrence. It did the exact opposite. It increased bv, mainly because you washed out all the protective lactobacilli. You just cleared out the police from the environment. So the bad players then kicked it up a notch. And it also increased rates of other infections, including pid. So Duchenne is terrible. That's a no, no. We know not to do that. And so that kind of points against the idea that, well, maybe just because you can remove semen from the vagina quickly isn't always a good thing in terms of washing out other bacteria. And that's my concern here, is that while it's absorbing semen and the alkaline pH material, it's also taking away the good secretions from the vagina. So there's a lot of things to be seen here. And I don't know if this is going to last on the market. If it's going to be like a multi billion dollar. Like a douching company is multi million dollar. We don't know. But we know that douching does not work. We do not know if this device is going to make a dent in recurrent bv. Remember that ACOG has endorsed partner treatment or treatment of the male partner for recurrent BV prevention. That's possible. We've covered that on the show. Vaginal acidification has fair data. It's moderate strength, fine. And even vaginal probiotics may have a role again, either as standalone or as adjuvant or traditional antibiotics. Those are all very conflicting, but they do have some moderate benefit over nothing at all. Okay, so I understand very well that BV sucks. I mean, it does. I get it. Is this good? Is this the ultimate answer? I don't know. I don't know. There's so many other things that can be looked at. So this is coming out. And again, even though I put it on our Instagram, in case a patient asks you what you think about this, you're not blindsided. My answer is going to be, we just don't know. If it makes you feel better after sex and you want to spend whatever it costs to go get this, fine. I have two precautionary notes here. Number one, don't leave that in for longer than 15 minutes because we don't want it to adversely negatively affect the vagina by absorbing too much of the good fluid out. So make sure you adhere to that timeline. And number two, don't forget it in there, because I could just see. Oh, my goodness, like the forgotten tampon, which I've had many patients, had that experience over my 25 years of practice, and I just don't want that to happen. So I don't know what this is going to do in the market, but just true to form, I wanted to let you know what's coming out very quickly on the market. And because this is getting some social media hits as well, the Livy post intercourse vaginal absorption device. I don't know. We know that semen exposure is binary. It is unclear if residence time matters. So it is. It's just unknown. All right, podcast families, this is just a quickie episode to let you know what is out there. Get ready for Livy. It's coming on the market real soon. Podcast family, as always, we're thankful for you. We're glad you're part of our podcast community. And now that we've done all that, let's take it home. This is Dr. Chapma's ob gyn no spin podcast.

[Pharmaceutical Advertiser]

It.